Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors

International Journal of Gynecological Pathology

Volumn 31, Issue 5, 2012, Pages 463-469

  Mills, Anne M ^a   Liou, Sofia ^a   Kong, Christina S ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocervical adenocarcinoma; Hereditary nonpolyposis colorectal cancer syndrome; Lynch syndrome; Microsatellite instability; Mismatch repair proteins

Indexed keywords

MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESONEPHROMA; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; HUMANS; RISK; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 84864860090     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31824a1dad     Document Type: Article

References (25)

1. Hampel H, Frankel W, Panescu J, et al. Screening for lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006;66:7810-17 (Pubitemid 44289242)
2. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10 (Pubitemid 27033972)
3. Gruber SB, Thompson WD. A population-based study of endometrial cancer and familial risk in younger women. Cancer and steroid hormone study group. Cancer Epidemiol Biomarkers Prev 1996;5:411-7 (Pubitemid 26182653)
4. Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Familial Cancer 2001;1:57-60
5. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85 (Pubitemid 23051366)
6. Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a ''sentinel cancer'' for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 2005;105:569-74 (Pubitemid 40271224)
7. Westin SN, Lacour RA, Urbauer DL, et al. Carcinoma of the lower uterine segment: a newly described association with lynch syndrome. J Clin Oncol 2008;26:5965-71
8. Kong C, Beck A, Longacre T. A panel of three markers including p16, proex c, or hpv ish is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas. Am J Surg Pathol 2010;34:915-26
9. Garg K, Leitao MM Jr, Kauff ND, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol 2009;33:925-33
10. Walsh CS, Blum A, Walts A, et al. Lynch syndrome among gynecologic oncology patients meeting bethesda guidelines for screening. Gynecol Oncol 2010;116:516-21
11. Resnick KE, Hampel H, Fishel R, et al. Current and emerging trends in lynch syndrome identification in women with endometrial cancer. Gynecol Oncol 2009;114:128-34
12. Resnick K, Straughn JM Jr, Backes F, et al. Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients. Obstet Gynecol 2009;114:530-6
13. Lancaster JM, Powell CB, Kauff ND, et al. Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 2007;107:159-62 (Pubitemid 47575743)
14. Umar A, Boland CR, Terdiman JP, et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8 (Pubitemid 38256271)
15. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (hnpcc, lynch syndrome) proposed by the international collaborative group on hnpcc. Gastroenterology 1999;116:1453-6 (Pubitemid 29258894)
16. BerendsMJ,Wu Y, Sijmons RH, et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 2003;21:4364-70 (Pubitemid 46621813)
17. Kwon JS, Scott JL, Gilks CB, et al. Testing women with endometrial cancer to detect lynch syndrome. J Clin Oncol 2011;29:2247-52
18. Mojtahed A, Schrijver I, Ford JM, et al. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol 2011;24:1004-14
19. Lu KH, Schorge JO, Rodabaugh KJ, et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol 2007;25:5158-64 (Pubitemid 350232246)
20. Boyd J. Specific keynote: hereditary ovarian cancer: what we know. Gynecol Oncol 2003;88:S8-10; discussion S11-S13
21. Bermejo JL, Eng C, Hemminki K. Cancer characteristics in swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer. Gastroenterology 2005;129:1889-99 (Pubitemid 41781949)
22. Lynch L, O'Donoghue D, Dean J, et al. Detection and characterization of hemopoietic stem cells in the adult human small intestine. J Immunol 2006;176:5199-204
23. Mongiat-Artus P, Miquel C, Flejou JF, et al. Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer. Virchows Arch 2006;449:238-43
24. Ou CY, Chang JG, Tseng HH, et al. Analysis of microsatellite instability in cervical cancer. Int J Gynecol Cancer 1999;9: 67-71
25. Helland A, Borresen-Dale AL, Peltomaki P, et al. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 1997;70:499-501. (Pubitemid 27149630)